ClinicalTrials.gg
Sign In

Ascites clinical trials

The registry lists 247 studies for Ascites across more than 10 countries. 57 are recruiting or about to start. 148 of them are mainly about Ascites (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09.

Get an email when these change. Save the Ascites studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
110
Status unknown
42
Recruiting
41
Terminated
19
Withdrawn
12
Not yet recruiting
11

Phase

Phase 2
63
Phase 3
47
Phase 1
21
Phase 4
19

Where

United States
63
China
43
Germany
21
Italy
21
Spain
19
France
19

Who runs them

Sequana Medical N.V. (8) · Post Graduate Institute of Medical Education and Research, Chandigarh (8) · Sanofi (7) · Assiut University (6) · Protgen Ltd (4) · Otsuka Pharmaceutical Co., Ltd. (4) · University of Michigan (4) · University of Turin, Italy (3)

What is being tested here

Drugs under test in Ascites studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Albumins225
Atorvastatin112
Empagliflozin102
Carvedilol102
Amino Acids, Branched-Chain112
Dapagliflozin101
Apixaban101
Tolvaptan0510
Midodrine048
Satavaptan036

Drug classes tested here SGLT2 inhibitors 2 open · Beta blockers 1 open · Diuretics 3

Coming up

6phase 3 studies under way
17studies finish main data collection within a year1 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 41 Ascites studies recruiting now, 21 (51%) set no upper age limit and 13 (32%) stop at 75 or younger. 1 (2%) take children under 18. 3 (7%) are for women only and 0 (0%) for men only; 2 (5%) take healthy volunteers.

Recruiting studies that take each age, of 41
AgeWomenMen
101 (2%)1 (2%)
1839 (95%)36 (88%)
3040 (98%)37 (90%)
4040 (98%)37 (90%)
5040 (98%)37 (90%)
6540 (98%)37 (90%)
7536 (88%)33 (80%)
8524 (59%)21 (51%)

Across all 247 studies, recruiting or not: 33% stop at 75 or younger and 9% at 65; 8% take children; 5% are for women only and 1% for men only; 5% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Ascites studies take

Of 13 phase 3 interventional studies under Ascites, half reached primary completion within 28 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 328 mo16–49 · 13 studies——
Interventional, no phase32 mo21–62 · 33 studies——
Observational50 mo20–… · 28 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 11, 2026.

Newly registered3

Studies

Recruiting first, then most recently updated. Showing 50 of 247. Browse all 247 → or search them.